Citation:U.S. National Library of Medicine 2016
U.S. National Library of Medicine. clinicaltrials.gov. [homepage on the internet] USA: NIH; 2016 Dec 1 [cited 2019 May 24; updated 2019 May 21]. Available from: https://clinicaltrials.gov/ct2/show/NCT02978625.
This is a publication of NCT02978625
Compare quality appraisals for each clinical question
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers